Somanetics Corporation to Release Second Quarter 2008 Financial Results and Host Conference Call June 18, 2008

TROY, Mich., June 5 /PRNewswire-FirstCall/ -- Somanetics Corporation
(Nasdaq: SMTS) will release its financial results for the second quarter
ended May 31, 2008 before the opening of the market on Wednesday, June 18,
2008. In conjunction with its financial results, the Company will host a
conference call that will be webcast live at 10:00 a.m. (ET) the same day.

On the conference call, Bruce Barrett, Somanetics' president and chief
executive officer, and Bill Iacona, chief financial officer, will review
Somanetics' financial results.

To listen to the webcast, visit the Investor Center page of Somanetics'
website at http://www.somanetics.com 15 minutes prior to the event's
broadcast and click on the "Second Quarter 2008 Conference Call" link.
Interested parties unable to listen to the live call may access the
archived version of the call on the Investor Center page of Somanetics'
website for one year after the call. Windows Media Player is required for
access to the webcast and is available for downloading free of charge on
the webcast page.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and
markets the INVOS(R) Cerebral/Somatic Oximeter System, a non-invasive
patient monitoring system that continuously measures changes in the blood
oxygen levels in the brain and elsewhere in the body in patients with or at
risk for restricted blood flow. Surgeons, anesthesiologists and other
medical professionals can use the information provided by the INVOS System,
in conjunction with other available information, to identify oxygen
imbalances in tissues beneath the sensor and take necessary corrective
action, potentially improving patient outcomes and reducing the costs of
care. Somanetics supports its customers through a direct U.S. sales force
and clinical education team. Covidien markets INVOS System products in
Europe, Canada, the Middle East and South Africa and Edwards Lifesciences
represents INVOS System products in Japan. For more information visit
http://www.somanetics.com .

See Also:

• Luxury Bath and Body Company Puts a Relaxing Spin on the Fight Against Breast Cancer



• Never Too Late To Get Your Life Back



• Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkin's Lymphoma



• Martin, Harding and Mazzotti Successfully Run Memorial Day “Safe Ride Home” Program to Lower Drunken Driving Incidents



• ChemDiv to Provide Schering Plough Corporation With Discovery Libraries in Multiyear Agreement

[Via Healthcare]